Arkadios Wealth Advisors Sells 1,182 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Arkadios Wealth Advisors cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 5.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 21,562 shares of the pharmacy operator’s stock after selling 1,182 shares during the quarter. Arkadios Wealth Advisors’ holdings in Walgreens Boots Alliance were worth $201,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Charles Schwab Investment Management Inc. increased its position in shares of Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after acquiring an additional 3,329,857 shares during the period. Altrius Capital Management Inc increased its holdings in Walgreens Boots Alliance by 76.6% during the third quarter. Altrius Capital Management Inc now owns 440,483 shares of the pharmacy operator’s stock valued at $3,947,000 after buying an additional 190,996 shares during the period. PNC Financial Services Group Inc. increased its holdings in Walgreens Boots Alliance by 23.4% during the third quarter. PNC Financial Services Group Inc. now owns 340,431 shares of the pharmacy operator’s stock valued at $3,050,000 after buying an additional 64,586 shares during the period. Sasco Capital Inc. CT increased its holdings in Walgreens Boots Alliance by 13.6% during the third quarter. Sasco Capital Inc. CT now owns 1,041,440 shares of the pharmacy operator’s stock valued at $9,331,000 after buying an additional 124,950 shares during the period. Finally, Sunbelt Securities Inc. increased its holdings in Walgreens Boots Alliance by 82.8% during the third quarter. Sunbelt Securities Inc. now owns 139,377 shares of the pharmacy operator’s stock valued at $1,249,000 after buying an additional 63,149 shares during the period. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Trading Up 1.1 %

NASDAQ WBA opened at $11.87 on Friday. The company has a market capitalization of $10.26 billion, a PE ratio of -1.16, a P/E/G ratio of 1.46 and a beta of 0.64. The company has a fifty day moving average of $9.79 and a 200 day moving average of $9.87. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $23.76. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.66 earnings per share. Research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.59 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Evercore ISI lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Bank of America lifted their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. Truist Financial lifted their price target on shares of Walgreens Boots Alliance from $10.00 to $13.00 and gave the stock a “hold” rating in a report on Thursday, January 16th. Finally, Barclays lifted their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 16th. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $13.27.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.